Cultured porcine aortic endothelial cells were conditioned through two passages to mimic euglycemic and hyperglycemic conditions (5.2 mM, normal glucose; 15.6 mM, elevated glucose). After incubation with 1 ,uM I'4Clarachidonic acid for 24 h, the cells were stimulated with 1 ,uM A23187 for times up to 30 min. Uptake of ['4Clarachidonic acid and its distribution among cell lipids were unaffected by the increased glucose concentration. The release of eicosanoids from labeled cells and unlabeled cells was measured by reverse-phase HPLC and by RIA, respectively. Compared with cells stimulated in the presence of normal glucose concentrations, cells stimulated in the presence of elevated glucose released 62.6% less free 114q-arachidonic acid, but released 129% more 14C-labeled 15-hydroxyeicosatetraenoic acid (HETE). Increased release of 15-HETE in the presence of elevated glucose in response to A23187, bradykinin, and thrombin was confirmed by RIA. A similar increase in 5-HETE release was observed by RIA after A23187 treatment. The release of both radiolabeled and unlabeled prostanoids was equal at both glucose concentrations. The data indicate that glucose may play an important role in the regulation of release and metabolism of arachidonic acid after agonist stimulation. In the presence of elevated glucose concentrations, such as those associated with diabetes mellitus, the extent and pattern of eicosanoid release from endothelial cells is markedly altered.
Introduction
Altered eicosanoid production is among the many factors implicated in the pathogenesis of diabetic vascular disease. Both elevated platelet TXA2 and diminished vascular prostacyclin (PGI2) synthesis have been reported (1, 2) . In addition to cyclooxygenase-derived products, both platelets and endothelial cells produce hydroxyeicosatetraenoic acids (HETEs),1 metabolized by the lipoxygenase pathway of arachidonic acid oxygenation (3) (4) (5) (6) (7) . Several studies have suggested that these HETEs may influence the production of PGI2 (7, 8) . Glucose has been shown to enhance the production of 12-HETE in pancreatic islet cells (9, 10) .
Our present studies were undertaken to examine the effect ofglucose on eicosanoid production by cultured porcine aortic endothelial cells. Eicosanoid biosynthesis was induced by both receptor-mediated (bradykinin and thrombin) and receptorindependent (ionophore A23187) agonists. Our data demonstrate that, regardless of the stimulus used, an increased glucose concentration strikingly augments the production of 15-HETE but diminishes the release of free arachidonic acid.
Methods
Culture and conditioning of porcine aortic endothelial cells. Porcine aortic endothelial cells were isolated and cultured by methods previously described (1 1, 12) . Cells were cultured in DME containing 10% FCS (Biofluids, Rockville, MD) and 1,000 U/ml of penicillin G and 100 ,gg/ml of streptomycin. This complete medium was replaced every 2 d and used throughout subsequent cultures unless otherwise stated. At confluence, the aortic endothelial cells appeared as typical "cobblestone" patterned monolayers and stained positively for the acetylated low density lipoprotein receptor and the Factor VIII-related antigen.
Cells were subcultured by exposure to 0.05% trypsin (Type I; Sigma Chemical Co., St. Louis, MO), 0.02% EDTA in Ca2", Mg2+-free HBSS, pH 7.4, using a split ratio of 1:4. After the second to third passage, cells were divided into two groups and grown through two passages under conditions of normal glucose (5.2 mM; G-N cells) and elevated glucose (15.6 mM; G-E cells). All media used during subsequent labeling and stimulation contained the above concentrations ofglucose. All glucose supplements were conducted by the addition off3-D(+)-glucose (Sigma Chemical Co.) to the culture medium. All experiments utilized cultured cell monolayers that were confluent. Cell proliferation. After the first passage under G-N or G-E conditions, confluent cultures were trypsinized and subcultured at a split ratio of 1:4 into their respective culture conditions. Daily cell counts were performed, after dispersion with trypsin, using a hemocytometer. Cell doubling times were obtained from the linear portion of the curve obtained by plotting the log cell number against the number ofhours in culture.
Protein determination. Total protein was determined by a protein assay system according to the manufacturer's instructions (Bio-Rad Laboratories, Richmond, CA) using BSA as the standard. Cellular material used for protein determinations was obtained as follows.
Confluent cell cultures in 100-mm dishes were washed three times with 5 ml of Ca2", Mg2+-free HBSS and digested directly with 2.5 ml of 1 M NaOH overnight at ambient temperature. The digest was neutralized with 2. (15.6 mM) were identical to those performed in normal glucose. Other assay conditions were as previously described ( 13) .
Results
In preliminary experiments we observed that increasing the concentration of glucose in the culture medium had no effect on the net uptake of [ Fig. 1 Fig. 4 . At all time points, the release of 5-HETE from G-E cells was greater than from G-N cells, although the absolute difference was not statistically significant. The initial release of 1 5-HETE was similar from both groups of cells, but G-E cells released more 1 5-HETE at later time points (a significant increment of 129% at 30 min).
In experiments not using radiolabeled arachidonic acid, the release of 1 5-HETE, 5-HETE, and 6-keto-PGF1a was measured directly by RIA (Tables I-III) . These mass determinations confirmed that between 10 and 30 min G-E cells released greater amounts of 5-and 15-HETE, but not 6-keto-PGFia. Although the various agonists resulted in different absolute amounts of eicosanoids released, significant increases were observed for 15-HETE, independent of the agonist used. A significant increase in the release of 5-HETE by G-E cells was noted after stimulation with the ionophore. Elevation of the glucose concentration was without effect on agonist-induced release of 6-keto-PGFIa.
In other experiments, confluent cultures were incubated with 1 ,uM unlabeled arachidonic acid (NuChek Prep., Elysian, MN) bound to 1 AtM BSA in complete medium for 24 h before stimulation. Levels of immunoreactive 15-HETE, 5-HETE, and 6-keto-PGFIa measured under these conditions were essentially identical to those measured in experiments without exogenous arachidonic acid addition (data not shown).
Discussion
Our experiments were undertaken to determine if increased glucose concentrations influenced the rate and pattern of eicosanoid elaboration by stimulated endothelial cells. The preliminary data presented in the text and the more detailed data in Fig. 1 demonstrate that elevated glucose had no effect on the initial release of total '4C radioactivity from cells labeled with production. However, the time-dependent suppression of total 14C radioactivity released from prelabeled cells has not been previously documented.
The influence of elevated glucose on ionophore-induced eicosanoid release is apparently specific for the 1-isomer of glucose as illustrated in Fig. 2 . Neither sucrose, nor the optical isomer, L-glucose, is metabolized by endothelial cells, but each would increase the osmolarity of the medium. L-glucose could potentially mediate any effects due to nonenzymatic glycosylation of proteins. However, diminished release of eicosanoids was not observed for these sugars eliminating hyperosmolarity as well as protein glycosylation as potential causes of the decreased release. D-mannose, a geometric isomer ofglucose, can enter the glycolytic pathway. Since mannose was without effect, intermediary metabolites of glycolysis would probably also be without effect. Porcine aortic endothelial cells in culture were conditioned in two concentrations of glucose stimulated with A23 187 (1 MiM), bradykinin (1 gM) or thrombin (2.5 U/ml) and 5-HETE was measured by RIA (see legend to Table I ). Data are presented as the mean±SE of 5 experiments performed in duplicate. * P < 0.05 (paired t test). Porcine aortic endothelial cells in culture were conditioned in two concentrations of glucose, stimulated with the ionophore A23 187 (1 AM), bradykinin (1 AM), or thrombin (2.5 U/ml) and 6-keto-PGFI was measured by RIA (see legend to Table I ). Data are presented as the mean±SE of five experiments performed in duplicate.
The data illustrated in Figs. 3 and 4 demonstrate that increased glucose concentration in the medium exerted a disparate effect on the release of free ['4C]arachidonic acid and HETEs. The data shown in Fig. 4 and Tables I and II demonstrate that porcine endothelial cells produce both 5-and 15-HETE, as has been previously indicated for human umbilical endothelial cells (5, 6) . The decreased net release of arachidonic acid was evident after 5 min and was striking after 30 min. In sharp contrast, increasing the glucose concentration in the medium stimulated the release of both 5-and 15-HETE. The absolute magnitude ofthe suppression of [4C]arachidonic acid release overshadowed the enhanced HETE production, resulting in the net decrease in total`4C radioactivity release from G-E cells. The observation that increased glucose concentration increased ionophore-induced release of 5-and 15-HETE was confirmed in both the radiolabel experiments and those measuring mass by RIA. The magnitude ofthe increased HETE measured was not identical for the two techniques. However, since the specific activity of ['4C]arachidonic acid in the phospholipid precursor pools was unknown, absolute differences in the magnitude of the effect between mass measurements and net release of radioactivity is not surprising.
Glucose may exert its effects on free arachidonic acid and HETE release by independent mechanisms. Alternatively, it is possible that the enhanced production of HETE may itself exert an inhibitory effect on phospholipase activity. Lipoxygenase-derived products have been demonstrated to exhibit remarkably diverse effects on phospholipase activity in various cell types. Thus, studies from this laboratory have demonstrated that 15-HPETE, but not 1 5-HETE stimulates the net release of arachidonic acid from calf aortic endothelial cells (16) . In human neutrophils, 5-HPETE and 5-HETE augmented phospholipase A2 activity in response to ionophore, but 8-HETE and 15-HETE were ineffective (17) . In contrast, Chang and associates (18) have shown that 5-HETE, 12-HETE, and 15-HETE all inhibited platelet phospholipase A2 activity. These studies suggest that the decreased release of arachidonic acid under G-E conditions may be mediated by increased HETE generation.
Sagone et al. (19) have shown glucose to be a weak hydroxyl radical (OH') scavenger in biological systems. These investigators associated the OH' scavenging capacity ofglucose with its ability to increase the synthesis of HETE and HPETE. Hydroxyl radicals generated during lipoxygenase activity have been suggested to inhibit lipoxygenase itself (20) . Elevation of the glucose concentration had no effect on the release of cyclooxygenase products. The observation that OH' is not generated during cyclooxygenase activity ( 19, 20) is consistent with the lack of effect of increased glucose concentration on the elaboration of cyclooxygenase products. Indeed, the time course of prostaglandin production we observed was very rapid relative to lipoxygenase-product release. It is possible that cyclooxygenase activity would already itselfbe self-limited before augmented lipoxygenase activity could result in the accumulation of inhibitory concentrations of metabolites.
The decreased amounts of ["4C]arachidonic acid in the medium of stimulated G-E cells at later time points could be due to increased reacylation of arachidonic acid in the presence of increased glucose, which could be acting independently or in concert with a phospholipase inhibitory mechanism. Laychock (21) reported that 25 mM glucose stimulated the incorporation of ['4C]arachidonic acid into phosphatidylinositol and phosphatidylcholine of pancreatic islet cells. In other experiments it was observed that glucose activated a crude phospholipase A2 preparation from islet cells, suggesting a direct role of glucose in the acylation/reacylation of arachidonic acid (22) . Recently, Goppelt-Struebe et al. (23) reported that during activation of rat peritoneal macrophages concomitant reacylation reactions could modulate eicosanoid release. This group suggested that merthiolate could effectively inhibit the reacylation mechanism in a time-and dose-dependent manner. We are currently evaluating the utility ofsuch agents in delineating the pathways responsible for the net decrease in free arachidonic acid released from endothelial cells in the presence of elevated glucose.
The physiological significance of the inhibitory effect of glucose on mobilization of arachidonic acid is not clear. However, it is of interest that glucose also inhibits the closure ofthe rostral neural tube in mouse embryo cultures and that this teratogenic effect can be reversed by the addition of arachidonic acid to the medium (24). Furthermore, the administration ofarachidonic acid to pregnant diabetic rats prevented the fetal neural tube defects found in untreated controls. These data suggest that hyperglycemia-induced teratogenesis may be mediated by a functional deficiency of arachidonic acid (24).
Our observation of enhanced 1 5-HETE synthesis by endothelial cells exposed to increase glucose is consistent with that of Setty and Stuart (7) . These investigators found that segments of human umbilical arteries obtained from infants of diabetic mothers produced significantly more 1 5-HETE than similar vascular segments from infants of normal mothers.
The current data do not provide a direct explanation for the observed effects of increased glucose on endothelial eicosanoid metabolism. Whatever mechanism is operative, it must be induced within 2 h of exposure to elevated glucose and reversed within 2 h of restoration of normal glucose levels. Short-term changes in the polyol pathway of glucose metabolism or the rapid glycosylation of regulatory enzymes are attractive candidates, but how such changes are reflected in either phospholipase or lipoxygenase activities remains to be explained. The alteration of receptors is a less appealing explanation since ionophore-induced, as well as bradykinin-induced, eicosanoid metabolism are altered by high glucose. These possibilities are under investigation in our laboratories.
Such studies may provide new information on sites of regulation of arachidonic acid metabolism and their perturbation in diabetes mellitus.
